The use of atypical antipsychotics in dementia: Rethinking Simpson's paradox

International Psychogeriatrics

Volumn 21, Issue 4, 2009, Pages 616-621

  Suh, Guk Hee ^a  

^a Hallym University Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; DROPERIDOL; FUROSEMIDE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SERTINDOLE;

AGED; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BEHAVIOR DISORDER; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DATA ANALYSIS; DEHYDRATION; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EDITORIAL; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HEMOCONCENTRATION; HIGH RISK POPULATION; HUMAN; HYPERPROLACTINEMIA; INFECTION; MENTAL DISEASE; ORTHOSTATIC HYPOTENSION; PNEUMONIA; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; SIMPSON PARADOX; STATISTICAL PARAMETERS; STROKE; SUDDEN DEATH; THROMBOEMBOLISM; TORSADE DES POINTES; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; BIAS (EPIDEMIOLOGY); CEREBRAL INFARCTION; DEATH, SUDDEN, CARDIAC; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TORSADES DE POINTES;

EID: 69549097398     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610209008485     Document Type: Editorial

References (29)

1. Barnett, M. J., Perry, P. J., Alexander, B. and Kaboli, P. J. (2006). Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients. Journal of Clinical Psychopharmacology, 26, 182-187. (Pubitemid 43740344)
2. Barnett, M. J., Wehring, H. and Perry, P. J. (2007). Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users. Journal of Clinical Psychopharmacology, 27, 595-601. (Pubitemid 351339446)
3. Brodaty, H. et al. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. Journal of Clinical Psychiatry, 64, 134-143. (Pubitemid 36268315)
4. CLASP Collaborative Group (1994). CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet, 343, 619-629.
5. Committee of Safety of Medicines (CSM) (2004). Atypical antipsychotics and stroke. http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/messages/ risperidoneclinicaltrialdatafinal.pdf. Last accessed 13 May 2004.
6. Food and Drug Administration (FDA) (2005). Public health advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. http://www.fda.gov/cder/drug/advisory/antipsychotics.htm. Last accessed 22 April 2005.
7. Gill, S. S. et al. (2007). Antipsychotics use and mortality in older adults with dementia. Annals of Internal Medicine, 146, 775-786. (Pubitemid 351650498)
8. Gruppo Italiano per lo Studio della Streptochinasi Nell'Infarco Miocardico (GISSI) (1994). GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet, 343, 1115-1122.
9. Haupt, M., Cruz-Jentoft, A. and Jeste, D. (2006). Mortality in elderly dementia patients treated with risperidone. Journal of Clinical Psychopharmacology, 26, 566-570. (Pubitemid 44772732)
10. Herrmann, N., Mamdani, M. and Lanctôt, K. L. (2004). Atypical antipsychotics and risk of cerebrovascular accidents. American Journal of Psychiatry, 161, 1113-1115. (Pubitemid 38736000)
11. Herrmann, N., Lanctôt, K. and Mandani, M. (2005). Psychotropic medication and stroke outcome. American Journal of Psychiatry, 162, 1027-1028.
12. Imperiale, T. E. and Petrullis, A. S. (1991). A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA, 266, 261-265.
13. ISIS-4 Collaboration Group (1995). ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium in 58,050 patients with suspected acute myocardial infarction. Lancet, 345, 669-685.
14. Nasrallah, H. A., Whit, T. and Nasrallah, A. (2004). Lower morality in geriatric patients receiving risperidone and olanzapine versus haloperidol. American Journal of Geriatric Psychiatry, 12, 437-439.
15. Nonino, F., Girolamo, G., Gamberini, L. and Goldoni, C. A. (2006). Survival among eldrly Italian patients with dementia treated with atypical antipsychotics: observational study. Neurological Sciences, 27, 375-380. (Pubitemid 46062650)
16. Raivio, M. M., Laurila, J. V., Strandberg, T. E., Tilvis, R. S. and Pitkala, K. H. (2007). Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. American Journal of Geriatric Psychiatry, 15, 416-424.
17. Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K. and Murray, K. T. (2001). Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry, 58, 1161-1167. (Pubitemid 33121508)
18. Schneeweiss, S., Setoguch, S., Brookhart, A., Dormuth, C. and Wang, P. S. (2007). Risk of death associated with the use of conventional versus atypical antipsychotics among elderly patients. Canadian Medical Association Journal, 176, 627-632. (Pubitemid 46426056)
19. Schneider, L. S., Dagerman, M. S. and Insel, P. S. (2006a). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191-210.
20. Schneider, L. S. et al. (2006b). Effectiveness of atypical antipsychotics in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525-1538. (Pubitemid 44547805)
21. Shah, A. and Suh, G. H. (2005). A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). International Psychogeriatrics, 17, 12-22. (Pubitemid 40593643)
22. Suh, G. H. and Shah, A. (2005). Effect of antipsychotics on mortality in elderly patients with dementia: a 1-year prospective study in a nursing home. International Psychogeriatrics, 17, 429-441.
23. Teagarden, J. R. (1989). Meta-analysis: whither narrative review? Pharmacotherapy, 9, 274-281.
24. Teo, K. K. et al. (1991). Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. British Medical Journal, 303, 1499-1503.
25. Trifiro, G. et al. (2007). All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiology and Drug Safety, 16, 538-544. (Pubitemid 46824275)
26. Verstraete, M. (2002). Value and limitation of meta-analysis. Pathophysiology of Haemostasis and Thrombosis, 32, 278-281.
27. Vilalta-Franch, J., Lopez-Pousa, S., Garre-Olmo, J., Turon-Estrada, A. and Pericot-Nierga, I. (2008). Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs. Revista de Neurologia, 46, 129-134.
28. Wagner, C. H. (1982). Simpson's paradox in real life. American Statistician, 36, 46-48.
29. Yusuf, S., Collins, R., MacMahon, S. and Peto, R. (1988). Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomized trials. Lancet, 14, 1088-1092. (Pubitemid 18120647)